[
  {
    "ts": null,
    "headline": "AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release",
    "summary": "AbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://finnhub.io/api/news?id=aa179e3192b2d4dd5fcf16e596654c71fa0f911160f0de02c25ed39c2f0187c0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753365625,
      "headline": "AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release",
      "id": 136084836,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
      "url": "https://finnhub.io/api/news?id=aa179e3192b2d4dd5fcf16e596654c71fa0f911160f0de02c25ed39c2f0187c0"
    }
  },
  {
    "ts": null,
    "headline": "J&J Innovative Medicine Unit Shines Again in Q2: Will This Continue?",
    "summary": "JNJ's Innovative Medicine unit posts solid Q2 growth despite Stelara's LOE, powered by Darzalex, Tremfya, Erleada and new drugs.",
    "url": "https://finnhub.io/api/news?id=b0c003928b0c797247e577d10b0d8ddb4ff152a4becfbdf922189047918cab24",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753363380,
      "headline": "J&J Innovative Medicine Unit Shines Again in Q2: Will This Continue?",
      "id": 136084819,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "JNJ's Innovative Medicine unit posts solid Q2 growth despite Stelara's LOE, powered by Darzalex, Tremfya, Erleada and new drugs.",
      "url": "https://finnhub.io/api/news?id=b0c003928b0c797247e577d10b0d8ddb4ff152a4becfbdf922189047918cab24"
    }
  },
  {
    "ts": null,
    "headline": "The 3 Things That Matter for AbbVie Now",
    "summary": "AbbVie's pair of immunology drugs is expected to help drive growth into the next decade.  The company should successfully improve its lineup thanks to its deep pipeline.  AbbVie can overcome tariff-related challenges and perform well over the long run.",
    "url": "https://finnhub.io/api/news?id=88a78e1bb9798d051d4e13a7cd3d378e5b3e2b99e0bd658e28a942181212b7ad",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753361100,
      "headline": "The 3 Things That Matter for AbbVie Now",
      "id": 136066260,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie's pair of immunology drugs is expected to help drive growth into the next decade.  The company should successfully improve its lineup thanks to its deep pipeline.  AbbVie can overcome tariff-related challenges and perform well over the long run.",
      "url": "https://finnhub.io/api/news?id=88a78e1bb9798d051d4e13a7cd3d378e5b3e2b99e0bd658e28a942181212b7ad"
    }
  },
  {
    "ts": null,
    "headline": "Fidelity Growth Company Fund Q2 2025 Commentary",
    "summary": "Fidelity Growth Company Fund beat its benchmark with smart AI bets like Nvidia and CoreWeave. See how itâs positioned for more. Explore the full review.",
    "url": "https://finnhub.io/api/news?id=5673cc286fe8ad1d7e8d33bae3e8a55fd552d86b240366db424591cbfd36df2d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753360500,
      "headline": "Fidelity Growth Company Fund Q2 2025 Commentary",
      "id": 136068440,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1367307631/image_1367307631.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Fidelity Growth Company Fund beat its benchmark with smart AI bets like Nvidia and CoreWeave. See how itâs positioned for more. Explore the full review.",
      "url": "https://finnhub.io/api/news?id=5673cc286fe8ad1d7e8d33bae3e8a55fd552d86b240366db424591cbfd36df2d"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Insiders Sell US$50m Of Stock, Possibly Signalling Caution",
    "summary": "The fact that multiple AbbVie Inc. ( NYSE:ABBV ) insiders offloaded a considerable amount of shares over the past year...",
    "url": "https://finnhub.io/api/news?id=ea4d55630bba901e797e010e2839fc27a7606a57e1bf1d9c322600c1337f05e1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753354914,
      "headline": "AbbVie Insiders Sell US$50m Of Stock, Possibly Signalling Caution",
      "id": 136066261,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "The fact that multiple AbbVie Inc. ( NYSE:ABBV ) insiders offloaded a considerable amount of shares over the past year...",
      "url": "https://finnhub.io/api/news?id=ea4d55630bba901e797e010e2839fc27a7606a57e1bf1d9c322600c1337f05e1"
    }
  },
  {
    "ts": null,
    "headline": "Behcet's Disease Market Research Report 2025-2035 | Key Trends, Regulatory Framework, Epidemiology, Clinical Trial Analysis, Market Dynamics",
    "summary": "The global Behcet’s Disease market is projected to grow significantly from 2025 to 2035 due to increasing prevalence and improved diagnosis, particularly in regions such as the Middle East, Asia, and the Mediterranean. Enhanced awareness and advanced diagnostic techniques facilitate earlier detection, expanding the treatment-seeking population. The adoption of targeted biologic therapies and immunosuppressive agents is driving demand, despite challenges like high costs and complex diagnoses. Key",
    "url": "https://finnhub.io/api/news?id=cc349ceaf2b0957a91548b4709b4832b59c19197d5333e1800b3a75307da98cf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753352160,
      "headline": "Behcet's Disease Market Research Report 2025-2035 | Key Trends, Regulatory Framework, Epidemiology, Clinical Trial Analysis, Market Dynamics",
      "id": 136066262,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "The global Behcet’s Disease market is projected to grow significantly from 2025 to 2035 due to increasing prevalence and improved diagnosis, particularly in regions such as the Middle East, Asia, and the Mediterranean. Enhanced awareness and advanced diagnostic techniques facilitate earlier detection, expanding the treatment-seeking population. The adoption of targeted biologic therapies and immunosuppressive agents is driving demand, despite challenges like high costs and complex diagnoses. Key",
      "url": "https://finnhub.io/api/news?id=cc349ceaf2b0957a91548b4709b4832b59c19197d5333e1800b3a75307da98cf"
    }
  },
  {
    "ts": null,
    "headline": "Diffuse Large B-cell Lymphoma Market Research Report 2025-2035 | Personalized Medicine and Precision Treatment Trends in DLBCL",
    "summary": "The Diffuse Large B-cell Lymphoma (DLBCL) market is witnessing significant growth, driven by advancements in targeted immunotherapies like CAR-T cell therapy and bispecific antibodies. These therapies are transforming the treatment landscape for relapsed or refractory cases, offering personalized, effective solutions. Despite exciting trends in precision medicine, the market faces challenges such as high treatment costs, resistance issues, and side effects associated with CAR-T therapy. However,",
    "url": "https://finnhub.io/api/news?id=acb747de31084bf7e4395f2a15d793cf18a3f91e9f2633ce65957db4eb27788c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753351140,
      "headline": "Diffuse Large B-cell Lymphoma Market Research Report 2025-2035 | Personalized Medicine and Precision Treatment Trends in DLBCL",
      "id": 136066252,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "The Diffuse Large B-cell Lymphoma (DLBCL) market is witnessing significant growth, driven by advancements in targeted immunotherapies like CAR-T cell therapy and bispecific antibodies. These therapies are transforming the treatment landscape for relapsed or refractory cases, offering personalized, effective solutions. Despite exciting trends in precision medicine, the market faces challenges such as high treatment costs, resistance issues, and side effects associated with CAR-T therapy. However,",
      "url": "https://finnhub.io/api/news?id=acb747de31084bf7e4395f2a15d793cf18a3f91e9f2633ce65957db4eb27788c"
    }
  },
  {
    "ts": null,
    "headline": "iOnctura Strengthens Medical and Commercialization Expertise with Two Non-Executive Board Appointments",
    "summary": "iOnctura, a clinical-stage precision oncology company combating neglected and hard-to-treat cancers, today announces the appointment of two Non-Executive Directors to its Board.",
    "url": "https://finnhub.io/api/news?id=cbceeceb9ec89071028d4ac1d4835b76e19367461a37dde3f4c7f02369d94218",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753344000,
      "headline": "iOnctura Strengthens Medical and Commercialization Expertise with Two Non-Executive Board Appointments",
      "id": 136066264,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "iOnctura, a clinical-stage precision oncology company combating neglected and hard-to-treat cancers, today announces the appointment of two Non-Executive Directors to its Board.",
      "url": "https://finnhub.io/api/news?id=cbceeceb9ec89071028d4ac1d4835b76e19367461a37dde3f4c7f02369d94218"
    }
  }
]